BioRestorative Therapies Inc. Registered Shares DL -,01

Sector and Industry

Consumer Non-Cyclicals, Household Products

Performance (1Y)

78.79%

Market Cap

12.51 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-1.40 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Procter & Gamble Co317.85 Bil.77.53 Bil.24.48
+6.80 %
0.00
-
L'Oreal S.A.195.68 Bil.44.05 Bil.31.93
-4.39 %
0.00
-
Unilever PLC121.38 Bil.50.55 Bil.20.33
-1.01 %
0.00
-
Midea Group Co. Ltd. 'H'70.60 Bil.56.38 Bil.13.51
+9.42 %
0.00
-
Colgate-Palmolive Co53.91 Bil.18.07 Bil.30.06
-29.24 %
0.00
-
Reckitt Benckiser Group PLC46.22 Bil.16.60 Bil.12.82
+121.23 %
0.00
-
Kimberly-Clark Corp28.51 Bil.14.58 Bil.16.63
-38.93 %
0.00
-
Kenvue Inc.28.05 Bil.13.41 Bil.22.50
+36.84 %
0.00
-
Estee Lauder Companies Inc24.76 Bil.13.14 Bil.-
-389.00 %
0.00
-
Beiersdorf AG 20.47 Bil.9.85 Bil.22.05
+2.96 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.28 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 03:31:59 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.2880.272
PREV. DAY'S PRICE0.28 (07/20)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW1.59 (09/01)0.127 (05/20)

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-2.28-1.07-1.40--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
0.821.1630.42--
PRICE - SALES RATIO
50.3427.6929.38--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A3C9XF
ISIN
US0906556065
SYMBOL
9OF
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
BIORESTORAT.THERAP.DL-,01
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYConsumer Non-Cyclicals, Household Products
NUMBER OF SHARES
6.77 Mil.
MARKET CAPITALISATION
12.51 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.76 %
-18.13 %
32.08 %
-70.21 %
-78.79 %
-89.63 %
-
-68.18 %
HIGH0.300.370.510.981.593.32-1.04
LOW0.280.280.130.130.130.13-0.13

Dividende

pro Aktie
BIORESTORAT.THERAP.DL-,01 does not deliver dividend information

Company profile

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.